Vibramycin side effects

Vibramycin (Doxycycline is an active component)

Indications for use

  1. Infectious inflammatory diseases caused by sensitive microorganisms: respiratory tract infections (pharyngitis, bronchopneumonia, lung abscess, acute and chronic bronchitis, tracheitis, lobar pneumonia, pleural empyema);
  2. Infections of ENT organs (otitis media, tonsillitis, sinusitis, etc.);
  3. Infections of the genitourinary system (gonorrhea, pyelonephritis, prostatitis, cystitis, urethritis, urethrocystitis, urogenital mycoplasmosis, endometritis, endocervicitis, acute orchypididitis);
  4. Infections of biliary and gastrointestinal tracts (cholecystitis, gastroenterocolitis, bacterial dysentery, cholangitis, traveler’s diarrhea);
  5. Infections of the skin and soft tissues (abscess, phlegmon, furunculosis, panaritium, wounds, infected burns, etc.);
  6. Infectious diseases of the eye, yawsinosis, legionellosis, syphilis, rickettsiosis, chlamydia of various localization (including prostatitis and proctitis), Q fever, Rocky Mountain spotted fever, typhus (including swelling, tick-borne relapsing fever), Lyme borreliosis (the first stage), bacillary and amoebic dysentery, tularemia, cholera, actinomycosis, malaria;
  7. In polytherapy use – leptospirosis, trachoma, psittacosis, ornithosis, granulocyte erlichiosis;
  8. Whooping cough, brucellosis, osteomyelitis;
  9. Sepsis, subacute septic endocarditis, peritonitis;
  10. Prevention of postoperative purulent complications;
  11. Malaria caused by Plasmodium falciparum during short trips (less than 4 months) in a territory where strains resistant to chloroquine and/or pyrimethamine sulfadoxine are common.


Vibramycin is contraindicated in the following cases:

  • hypersensitivity to the ingredients of Vibramycin;
  • porphyria;
  • severe hepatic insufficiency;
  • leukopenia;
  • pregnancy (II-III trimesters);
  • lactation period;
  • childhood (up to 8 years – the possibility of insoluble Ca2 complexes formation + bone deposition, deposition in the tooth enamel and dentin);
  • intravenous administration (myasthenia gravis).

Undesirable effects

The nervous system:

  • benign increased intracranial pressure (decreased appetite, vomiting, headache, edema of the optic nerve disc), toxic effects on the central nervous system (dizziness or instability).

The digestive system:

  • nausea;
  • constipation or diarrhea;
  • glossitis;
  • dysphagia;
  • esophagitis (including erosive);
  • gastritis;
  • gastric and duodenal ulcers;
  • enterocolitis (due to the proliferation of resistant Staphylococcus strains).

Allergic reactions:

  • maculopapular rash;
  • itchy skin;
  • skin hyperemia;
  • angioedema;
  • anaphylactoid reactions;
  • drug-induced lupus erythematosus.

The hematopoietic system:

  • hemolytic anemia;
  • thrombocytopenia;
  • neutropenia;
  • eosinophilia.

Other possible consequences:

  • candidiasis (vaginitis, glossitis, stomatitis, proctitis);
  • dysbacteriosis;
  • photosensitization;
  • superinfection;
  • tooth discolorization;
  • inflammation in the anogenital area.

Frequently used in all types of prostatitis. Vibramycin in prostate infections, vibramycin in prostatitis, vibramycin in acute prostatitis, vibramycin in chronic prostatitis, vibramycin in bacterial prostatitis, vibramycin in abacterial prostatitis